Scope of the
Report
The report entitled “The US Onychomycosis Market: Size, Trends & Forecasts (2016-2020)”, provides analysis of the US onychomycosis market, with detailed analysis of market size and growth, market share and economic impact of the industry. The analysis includes the market by value, by volume and by segments. The report also includes the detailed analysis of the segments of the onychomycosis market, comprising of market by value, by volume and by average prices.
The report entitled “The US Onychomycosis Market: Size, Trends & Forecasts (2016-2020)”, provides analysis of the US onychomycosis market, with detailed analysis of market size and growth, market share and economic impact of the industry. The analysis includes the market by value, by volume and by segments. The report also includes the detailed analysis of the segments of the onychomycosis market, comprising of market by value, by volume and by average prices.
Request a sample of
this report @ http://www.orbisresearch.com/contacts/request-sample/185392 .
Furthermore, the report also assesses the key opportunities in the market
and outlines the factors that are and will be driving the growth of the
industry. Growth of the overall onychomycosis market of the US has also been
forecasted, taking into consideration the previous growth patterns, the growth
drivers and the current and future trends.
Valeant Pharmaceuticals, Anacor Pharmaceuticals, Novartis AG and Johnson
& Johnson are some of the key players operating in the US onychomycosis
market, whose company profiling has been done in the report. In this segment of
the report, business overview, financial overview and business strategies of
the companies are provided.
Purchase a copy of
The US Onychomycosis Market
visit @ http://www.orbisresearch.com/contact/purchase/185392 For
more information contact sales@orbisresearch.com .
Company Coverage
Valeant Pharmaceuticals
Anacor Pharmaceuticals
Johnson & Johnson
Novartis AG
Valeant Pharmaceuticals
Anacor Pharmaceuticals
Johnson & Johnson
Novartis AG
Executive Summary
Onychomycosis is a condition of fungal nail infection. Onychomycosis begins in the nail bed and progresses to the nail plate, causing the nail to become discolored, deformed, and even separated from the nail bed. Onychomycosis has a significant chance of reoccurrence. Of all the nail abnormalities in the world, around 50% are the case of onychomycosis. In most of the cases it occurs in the toenails. Onychomycosis is not a life threatening disease but, may persist or worsen if not treated. Symptoms of onychomycosis are changes in appearance of the nail, interference with standing, walking, and exercising, pain, discomfort, etc. The causative pathogens of onychomycosis include dermatophytes (most common), Candida, and nondermatophytic molds.
Onychomycosis is a condition of fungal nail infection. Onychomycosis begins in the nail bed and progresses to the nail plate, causing the nail to become discolored, deformed, and even separated from the nail bed. Onychomycosis has a significant chance of reoccurrence. Of all the nail abnormalities in the world, around 50% are the case of onychomycosis. In most of the cases it occurs in the toenails. Onychomycosis is not a life threatening disease but, may persist or worsen if not treated. Symptoms of onychomycosis are changes in appearance of the nail, interference with standing, walking, and exercising, pain, discomfort, etc. The causative pathogens of onychomycosis include dermatophytes (most common), Candida, and nondermatophytic molds.
There are five types of Onychomycosis: Distal Subungual Onychomycosis,
White superficial onychomycosis, Proximal subungual onychomycosis, Endonyx
onychomycosis and Candidal onychomycosis. Two types of treatments are available
of onychomycosis: Oral Treatment and Topical Treatment. Oral treatment
includes: Terbinafine, Itraconazole, etc. and topical treatment includes
Kerydin, Jublia, etc. Nonpharmacologic approaches are also there, which
includes the following: Laser treatment, Photodynamic therapy, etc.
The US onychomycosis market (prescription drugs) has increased with a
healthy growth rate over the years and is expected to increase further during
the forecasted period. The US onychomycosis market is supported by various
growth drivers, such as rising per capita healthcare expenditure, increasing
diabetic patients, ageing population, introduction of new drugs, etc. Yet, the
market faces certain challenges, such as, reimbursements, low awareness, side
effects, etc.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/the-us-onychomycosis-market-size-trends-and-forecasts-2016-2020 .
Some points from TOC:
1. Executive Summary
2. Introduction
2.1 Onychomycosis: An Overview
2.1.1 Signs and Symptoms
2.1.2 Causes of Onychomycosis
2.2 Types of Onychomycosis
2.3 Treatment For Onychomycosis
2.1 Onychomycosis: An Overview
2.1.1 Signs and Symptoms
2.1.2 Causes of Onychomycosis
2.2 Types of Onychomycosis
2.3 Treatment For Onychomycosis
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact
Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1
(214) 884-6817; +9164101019
No comments:
Post a Comment